1. Molecular epidemiology of herpangina in the subcenter of Beijing, China: a surveillance study during 2021-2022.
- Author
-
Zhang WX, Zou L, Cui Y, Zhou Y, Zhang SS, Yang H, Ding S, Ma QY, Xi L, Zheng RR, Du J, Zhang J, and Lu QB
- Subjects
- Humans, Beijing epidemiology, Female, Child, Preschool, Child, Male, Enterovirus genetics, Enterovirus classification, Enterovirus isolation & purification, Infant, SARS-CoV-2 genetics, SARS-CoV-2 classification, SARS-CoV-2 isolation & purification, Enterovirus Infections epidemiology, Enterovirus Infections virology, Phylogeny, China epidemiology, Molecular Epidemiology, COVID-19 epidemiology, COVID-19 virology, Genotype
- Abstract
In this study, we analyzed the dynamic molecular epidemiology of herpangina based on pharyngeal swabs and demographic data collected from children with herpangina monitored in Tongzhou district in China from January 2021 to December 2022. A total of 1022 herpangina cases were diagnosed. Out of 225 samples collected, 56.4% (127/225) were positive for non-polio enterovirus, with seven genotypes identified: coxsackievirus A4 (CV-A4), CV-A6, CV-A10, CV-A2, CV-A16, CV-B3, and CV-A8. The predominant genotypes associated with herpangina changed during and after the COVID-19 pandemic, with the predominant genotypes being CV-A4 and CV-A6 in 2021 and CV-A10 and CV-A6 in 2022., Competing Interests: Declarations Conflict of interest The authors declare there are no competing interests. Ethical approval All of the participants provided informed consent. The Peking University Institutional Review Board Office granted ethical approval to carry out the study within its facilities (IRB00001052-19005)., (© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF